Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pierre Antoine Soret"'
Autor:
Julie Magusto, Carine Beaupère, Marta B. Afonso, Martine Auclair, Jean-Louis Delaunay, Pierre-Antoine Soret, Gilles Courtois, Tounsia Aït-Slimane, Chantal Housset, Isabelle Jéru, Bruno Fève, Vlad Ratziu, Cecilia M.P. Rodrigues, Jérémie Gautheron
Publikováno v:
iScience, Vol 25, Iss 10, Pp 105166- (2022)
Summary: Receptor-interacting protein kinase-3 (RIPK3) and mixed lineage kinase domain-like (MLKL) proteins are key regulators of necroptosis, a highly pro-inflammatory mode of cell death, which has been involved in various human diseases. Necroptoti
Externí odkaz:
https://doaj.org/article/144dbd8f28cf4b3c9179202e0635b2cb
Publikováno v:
La Revue du praticien. 71(8)
PRIMARY BILIARY CHOLANGITIS Primary biliary cholangitis (formally primary biliary cirrhosis, PBC) is the most common chronic cholestatic liver disease in humans. It is a presumed autoimmune liver disease, characterized by inflammation and progressive
Autor:
Pietro Invernizzi, Dominique Larrey, Thomas Berg, Christine Silvain, Christina Weiler-Normann, Rodolphe Anty, Cervoni Jp, Albert Parés, Cynthia Levy, Olivier Chazouillères, Laurent Lam, Christophe Bureau, Isabelle Rosa-Hezode, Palak J. Trivedi, Christoph Schramm, Nora Cazzagon, Laurent Alric, Vincent Leroy, Alexandra Heurgué, Frederik Nevens, Jérôme Dumortier, Pierre Antoine Soret, Olivier Roux, Marco Carbone, Fabrice Carrat, Pascal Potier, Lena Smets, Christophe Corpechot
Publikováno v:
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (10), pp.1138--1146. ⟨10.1111/apt.16336⟩
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (10), pp.1138--1146. ⟨10.1111/apt.16336⟩
Background: Obeticholic acid (OCA) and fibrates are second-line therapies for patients with primary biliary cholangitis (PBC) with an inadequate response to ursodeoxycholic acid (UDCA). Aim: To know whether OCA and fibrates, administered together in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f158862dc3423fdff68f823dc8ca1557
http://hdl.handle.net/11577/3395046
http://hdl.handle.net/11577/3395046
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, MDPI, 2020, 10 (1), pp.36. ⟨10.3390/jcm10010036⟩
Journal of Clinical Medicine, 2020, 10 (1), pp.36. ⟨10.3390/jcm10010036⟩
Journal of Clinical Medicine, Vol 10, Iss 36, p 36 (2021)
Journal of Clinical Medicine, MDPI, 2020, 10 (1), pp.36. ⟨10.3390/jcm10010036⟩
Journal of Clinical Medicine, 2020, 10 (1), pp.36. ⟨10.3390/jcm10010036⟩
Journal of Clinical Medicine, Vol 10, Iss 36, p 36 (2021)
International audience; Non-alcoholic fatty liver disease (NAFLD), including non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH), represents the hepatic manifestation of obesity and metabolic syndrome. Due to the spread of the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f5df186ea434ef9984b734261c5029
https://hal.sorbonne-universite.fr/hal-03146351/document
https://hal.sorbonne-universite.fr/hal-03146351/document
Autor:
André Kahan, Florence Morin, F. Chast, Vered Abitbol, Claire Goulvestre, Jérôme Avouac, Anna Molto, Pierre Antoine Soret, Axelle Salcion, Christian Roux, Claire Le Jeunne, Caroline Klotz, Stanislas Chaussade, Muriel Elhai, Adrien Etcheto, Loriane Gutermann, O. Conort, Pascal Cohen, Maxime Dougados, Yannick Allanore
Publikováno v:
Seminars in Arthritis and Rheumatism. 47:741-748
Objective To investigate effectiveness of systematic switching treatment from innovator infliximab to biosimilar infliximab, and its associated factors. Methods In this prospective observational study, all adult patients receiving maintenance therapy
Autor:
Caroline Prieux-Klotz, Maximilien Barret, Vered Abitbol, Pierre-Antoine Soret, Marie Dior, Claire Goulvestre, Jérôme Avouac, Stanislas Chaussade, Anna Molto, Bertrand Brieau, Claire Le Jeunne, François Chast, Romain Coriat, Johann Dreanic, Stéphane Nahon, O. Conort, Maxime Dougados, Marine Camus
Publikováno v:
Gastroenterology. 152:S402